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Abstract
Background: Involvement of trochlear nerve during Varicella Zoster Virus (VZV) Infection has been rarely described,
and always in association with skin rash.
Case presentation: We describe the case of a patient with VZV infection presenting as isolated diplopia due to
fourth cranial nerve palsy. The diagnosis has been obtained through the application of a standardized molecular
diagnostic panel, and diplopia resolved after specific antiviral and corticosteroid therapy.
Conclusion: This case evidences that clinicians should be aware of atypical VZV infection, even in the absence of
the typical skin rash.
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Background
Varicella Zoster Virus (VZV) often causes central ner-
vous system complications either during primary infec-
tion (chickenpox) and during reactivations. Neurological
involvement includes a wide spectrum of diseases, from
benign acute aseptic meningitis to severe manifestations,
with meningitis and encephalitis, acute cerebellar ataxia,
Guillain-Barré syndrome, Reye’s syndrome, myelitis, optic
neuritis more frequently reported in case of primary
varicella infection, and vasculopathy, focal motor weakness,
Ramsay-Hunt syndrome, post-herpetic neuralgia and
cranial nerves palsy more frequently reported in case of
reactivation [1,2].
The etiological diagnosis of these cases is often chal-
lenging for the clinicians, especially when these manifes-
tations occur without the typical vesicular rash [1,2].
Here we describe the case of an adult patient, immune-
competent and without underlying diseases, with fourth
nerve palsy, presenting diplopia as isolated symptom of
central nervous system involvement during VZV infection
without rash.
Methods
A specific search on PubMed about the occurrence of
nerve palsy during VZV infection has been performed,
using the terms “Varicella Zoster Virus Infection”, “Her-
pes Zoster”, “Shingles” and “Chickenpox” as major
topics, each matched with “nerve palsy”, or “neurological
complications”. The bibliography of relevant articles
have been checked to identify other significant papers.
Case presentation
A 33-year-old man was referred to the emergency
department and admitted (day 1) to a general hospital
for acute onset of isolated diplopia six hours prior. Seven
days prior to admission, he developed an unspecific
syndrome, characterized by mild headache, generalised
myalgia, vomiting and nausea without fever. Neuro-
logical examination was unremarkable except for vertical
and cross diplopia at left eye suggesting an isolated
fourth nerve palsy. Ocular examination including visual
field and fundoscope assessment were normal and no
pathological findings were observed on Brain CT Scan.
Cerebro-spinal fluid (CSF) analysis performed in the
same day showed pleocytosis (white blood cells count of
969/mm3 with normal value < 2/mm3, 80% lymphocytes),
proteins 188 mg/dl (normal value 8–32 mg/dl) and glu-
cose 51 mg/dl (normal value 40–70 mg/dl), with a blood
glucose of 111 mg/dl (normal value 70-110 mmg/dl).
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Gram stain was negative. The day after, in the suspicion
of a viral encephalitis, antiviral therapy with intravenous
acyclovir was started at the dose of 10 mg/kg every 8 -
hours and the patient was referred to our Infectious Dis-
eases hospital.
At admission in our hospital (day 2) his clinical condi-
tion was unchanged. We continued antiviral therapy and
added anti microbial therapy with ceftriaxone 2 grams
twice a day, and ampicillin 2 grams 6 times a day.
Diplopia persisted despite treatment, so on day 4 a
second lumbar puncture was performed. The CSF ana-
lysis showed 200 WBC/mm3 (normal value < 2/mm3),
protein 200 mg/dl (normal value 8–32 mg/dl) and glu-
cose 56 mg/dl (normal value 40–70 mg/dl), with a blood
glucose of 94 mg/dl (normal value 70-110 mmg/dl).
Routine tests were normal. Magnetic Resonance Imaging
(MRI) of the brain showed right sphenoid sinusitis only.
Chest X-ray was normal.
The agents most frequently responsible of meningo-
encephalitis were investigated: serological tests for VZV,
cytomegalovirus, herpes simplex virus 1–2, Epstein Barr
virus, measles virus, mumps virus, rubella virus, adeno-
virus, enterovirus, influenza and parainfluenza virus,
reovirus, respiratory syncytial virus, tick-borne encephal-
itis agents, West Nile virus, Toscana virus were all nega-
tive. A PCR performed on pharyngeal and rectal swab
resulted negative for enterovirus, adenovirus and respira-
tory viruses. Additional examinations included serology
for Brucella, Listeria, Treponema, Coxiella, Mycoplasma,
Chlamydia, Borrelia, Leptospira, Criptococcus antigen,
Quantiferon, HIV antigen and antibody test, Legionella
and pneumococcal urinary antigen, autoantibodies. All
these tests resulted negative.
A set of quantitative real-time PCR performed on
CSF was negative for herpes simplex virus 1–2, hu-
man herpes virus 6, cytomegalovirus, Epstein Barr
virus, enteroviruses, measles virus, mumps virus and
M. tubercolosis, while a quantitative real-time PCR
(HSV-VZV R-Gene Quantification Test, BiomerieuxW)
resulted positive for VZV-DNA, with a viral load of 30360
copies/ml.
On day 8 after initial admission, before a definitive
diagnosis was established, corticosteroid therapy with
oral prednisone was started at the initial dose of 50 mg
once daily and then at tapering dosages over a 40 days
course, as suggested by neurologist consultant. Partial
improvement of diplopia was observed after three days.
Antibiotics were stopped on day 12, while acyclovir was
continued up to day 14. The diplopia progressively
improved, and the patient was discharged on day 23.
Forty-five days later, the patient reported the complete
disappearance of diplopia. Full resolution of oculo-
motor impairment was evidenced by an Hess-Lancaster
test performed 3 months later.
Discussion
The impairment of central nervous system is not rare
during VZV infection. Indeed, VZV is now recognized
as one of the main cause of adult encephalitis: in recent
series on encephalitis from Europe, VZV has been
identified as the second most common etiology, remaining
Herpes Simplex the first one [3,4]. Diagnosis of VZV is usu-
ally suggested by the presence of the characteristic skin
rash. However, all neurological diseases following VZV
infection can occur in absence of the typical vesicles,
making the clinical suspicion of VZV challenging for the
clinician [1,2].
Neurological complications during VZV infection
include isolated cranial nerve palsies. The third and the
sixth nerve are most frequently involved as well as
peripheral facial palsy (Ramsay Hunt Syndrome), while
the involvement of the fourth nerve is rarely described,
and always in association with shingles or during herpes
zoster ophthalmicus [5,6].
Conversely, our patient presented with isolated diplopia
in absence of the typical rash and of any other signs of
neurological impairment, except for a mild headache a
week before. The diagnosis has been virologically demon-
strated by the detection of VZV-DNA in the CSF. It has
been possible through the application of extensive molecu-
lar test panel, based on PCR assays, on CSF. This panel
includes the most common infectious causes of neuro-
logical symptoms.
The diagnostic approach for neurological complica-
tions should be supported by PCR amplification of VZV
DNA in CSF and the search of intra-thecal IgG antibody
production, or specific IgM in the CSF. The detection of
intra-thecal IgG showed to be useful in the improvement
of VZV-related vasculopathy and myelopathy diagnosis,
when VZV is not detectable [7]. In our case the diagno-
sis was sustained by PCR, and intrathecal anti-VZV anti-
bodies were not investigated.
Antiviral therapy was promptly started, and corticoste-
roids were added at day 10. Some experiences suggested
the possible role of short-term corticosteroid therapy, in
adjunction to antiviral therapy, to reduce inflammation
[7]. Indeed, the pathogenesis of nerve palsy during VZV
infection is not fully understood. It may involve (i) a
direct cytopathic damage by retrograde spread of the
virus; (ii) a vasculopathy caused by active viral replica-
tion; or (iii) a circumscribed orbital myositis. Corticoste-
roids have been proposed for primary VZV encephalitis
and in immunocompetent patients with severe VZV
encephalitis and vasculopathy, but there are no definitive
data supporting their use [8].
Conclusion
This case shows that clinicians should be aware of the
role of VZV in neurological symptoms, even if the
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typical skin rash is not present. Indeed, if the role of
VZV is unrecognized, appropriate antiviral medications
may be discontinued early, once HSV is ruled out. The
application of a standardized panel on CSF, including
molecular tests for more common agents causing neuro-
logical impairment, could be very useful.
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